✦ LIBER ✦
8049 Cisplatin-based combination chemotherapy (CTX) consisting of docetaxel and cisplatin (DP) is still effective for patients with relapsed ovarian carcinoma (ROC) resistant or refractory to carboplatin-based CTX (TC: taxol/carboplatin)
✍ Scribed by Shimizu, Y.; Murakami, F.; Saitoh, N.; Yamasaki, A.; Ogawa, N.; Ishiya, T.; Katase, K.; Sakurai, S.
- Book ID
- 123555248
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 49 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.